These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14661392)

  • 1. [Managing patients with prostate cancer in Italy during the first year after diagnosis. A cost description based on a sample of 8 urological wards].
    Lazzaro C;
    Arch Ital Urol Androl; 2003 Sep; 75(3):138-49. PubMed ID: 14661392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The economics of managing patients with prostate cancer].
    Scattoni V; Lazzaro C; Rigatti P
    Arch Ital Urol Androl; 2003 Jun; 75(2):75-87. PubMed ID: 12868144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost of ICU in Italy. Results from an empirical study on a sample of 12 hospitals].
    Cavallo MC; Lazzaro C; Tabacchi M; Langer M; Salvo I; Serra G; Taddei C
    Minerva Anestesiol; 2001; 67(1-2):41-53. PubMed ID: 11279376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
    Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
    BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
    Xie J; Namjoshi M; Wu EQ; Parikh K; Diener M; Yu AP; Guo A; Culver KW
    J Manag Care Pharm; 2011 Oct; 17(8):621-43. PubMed ID: 21942303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of treatment and follow-up of bladder cancer in Italy.
    Racioppi M; Volpe A; Falabella R; Pinto F; Sacco E; Gulino G; D'Agostino D; Bassi PF
    Arch Ital Urol Androl; 2007 Sep; 79(3):111-7. PubMed ID: 18041361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.
    Surcel CI; Sooriakumaran P; Briganti A; De Visschere PJ; Fütterer JJ; Ghadjar P; Isbarn H; Ost P; Ploussard G; van den Bergh RC; van Oort IM; Yossepowitch O; Sedelaar JP; Giannarini G; ;
    BJU Int; 2015 Apr; 115(4):571-9. PubMed ID: 24802335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy.
    Fanelli A; Ruggeri M; Basile M; Cicchetti A; Coluzzi F; Della Rocca G; Di Marco P; Esposito C; Fanelli G; Grossi P; Leykin Y; Lorini FL; Paolicchi A; Scardino M; Corcione A
    Minerva Med; 2016 Feb; 107(1):1-13. PubMed ID: 26999384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
    Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
    Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey on policies of smoking control in Italian hospitals.
    Nardini S; Pacifici R; Mortali C; Zuccaro PG
    Monaldi Arch Chest Dis; 2003; 59(4):310-3. PubMed ID: 15148843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
    Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
    BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimated cost of managing invasive cervical cancer in Tunisia].
    Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.